What Is HMSN-6A?
HMSN-6A is a type of CMT caused by autosomal dominant mutations in the MFN2 gene. This gene provides instructions for making mitofusin-2, a protein that regulates the fusion and distribution of mitochondria within peripheral nerve cells. Mutations in the MFN2 gene disrupt this function, leading to impaired nerve signal transmission.
HMSN-6A is autosomal dominant, meaning that just one of the gene’s two copies needs a mutation to cause this subtype.
Clinical Features
The age of symptom onset in HMSN-6A is variable, ranging from childhood to adulthood. Symptoms typically begin in the lower extremities and progress over time to involve the upper limbs. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.
HMSN-6A symptoms may include:
- Weakness in the feet and lower legs
- Muscle atrophy
- Foot drop
- Reduced or absent reflexes
- Reduced sensation
- A steppage-style walking pattern
- Foot deformities, including high arches, and hammertoes (clawed toes)
- Progressive involvement of the hands and forearms
- Difficulty with fine motor skills and manual dexterity
- Additional symptoms not listed here
Disease Course
HMSN-6A shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.
